ISRCTN14227980已完成2 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia: a 12-week, randomised, double-blind, parallel-group, placebo controlled, international multicentre study
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 149 人开始时间: 2010年5月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 149
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Both genders patients between 18 years or legal age and 80 years
- •2. Symptomatic chronic heart failure for at least 6 months
- •3. Ischaemic disease or idiopathic dilated cardiomyopathy as main cause for chronic heart failure
排除标准
- •1. Women who are pregnant, breast-feeding or not using contraception
- •2. Recent myocardial infarction, unstable angina or coronary revascularisation less than 3 months before selection
- •3. History of stroke or cerebral transient ischemic attack within the previous 3 months before selection
研究者
相似试验
已完成
2 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.failure of the heart pump function10019280NL-OMON35783Servier R&D Benelux5
进行中(未招募)
1 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.EUCTR2009-014940-12-FRInstitut de Recherches Internationales Servier160
进行中(未招募)
1 期
Evaluation of the antiarrhythmic effects of 3 dosages of S 44121 versus placebo in patients with chronic heart failure at risk for ventricular arrhythmia.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 14.1Level: PTClassification code 10049694Term: Left ventricular dysfunctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10007558Term: Cardiac failure chronicSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10047281Term: Ventricular arrhythmiaSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-014940-12-BEInstitut de Recherches Internationales Servier160
进行中(未招募)
1 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 12.1Level: LLTClassification code 10007558Term: Cardiac failure chronicMedDRA version: 12.1Level: LLTClassification code 10049694Term: Left ventricular dysfunctionMedDRA version: 12.1Level: LLTClassification code 10047281Term: Ventricular arrhythmiaEUCTR2009-014940-12-HUInstitut de Recherches Internationales Servier160
进行中(未招募)
不适用
Evaluation of the antiarrhythmic effects of 3 dosages of S 44121 versus placebo in patients with chronic heart failure at risk for ventricular arrhythmia.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 14.1Level: PTClassification code 10049694Term: Left ventricular dysfunctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10007558Term: Cardiac failure chronicSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10047281Term: Ventricular arrhythmiaSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-014940-12-DEInstitut de Recherches Internationales Servier160
